F. Sautel, N. Griffon, P. Sokoloff, J. Schwartz, C. Launay et al., Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents, J Pharmacol Exp Ther, vol.275, pp.1239-1285, 1995.

M. Bouthenet, M. Martres, N. Sales, and J. Schwartz, A detailed mapping of dopamine D-2 receptors in rat central nervous system by autoradiography with [125I]iodosulpride, Neuroscience, vol.20, issue.1
DOI : 10.1016/0306-4522(87)90008-X

H. Ericson, A. Blomqvist, and C. Kohler, Brainstem afferents to the tuberomammillary nucleus in the rat brain with special reference to monoaminergic innervation, Journal of Comparative Neurology, vol.69, issue.Suppl., pp.169-92, 1989.
DOI : 10.1002/cne.902810203

J. Schwartz, J. Arrang, M. Garbarg, C. Gulat-marnay, and H. Pollard, Modulation of Histamine Synthesis and Release in Brain via Presynaptic Autoreceptors and Heteroreceptors, Annals of the New York Academy of Sciences, vol.95, issue.1 Presynaptic R
DOI : 10.1063/1.347120

C. Ito, K. Onodera, E. Sakurai, M. Sato, and T. Watanabe, Effects of dopamine antagonists on neuronal histamine release in the striatum of rats subjected to acute and chronic treatments with methamphetamine, J Pharmacol Exp Ther, vol.279, pp.271-277, 1996.

Y. Itoh, R. Oishi, M. Nishibori, and K. Saeki, Phencyclidine and the dynamics of mouse brain histamine, J Pharmacol Exp Ther, vol.235, pp.788-92, 1985.

Y. Itoh, R. Oishi, M. Nishibori, and K. Saeki, Comparison of effects of phencyclidine and methamphetamine on body temperature in mice: a possible role for histamine neurons in thermoregulation, Naunyn-Schmiedeberg's Archives of Pharmacology, vol.223, issue.3, pp.293-299, 1986.
DOI : 10.1007/BF00504870

R. Faucard, A. V. Heron, A. Cochois, V. Schwartz, J. Arrang et al., N-methyl-d-aspartate receptor antagonists enhance histamine neuron activity in rodent brain, Journal of Neurochemistry, vol.44, issue.5, pp.1487-96, 2006.
DOI : 10.1016/S0006-8993(97)00932-3

T. Nakai, N. Kitamura, T. Hashimoto, Y. Kajimoto, N. Nishino et al., Decreased histamine H1 receptors in the frontal cortex of brains from patients with chronic schizophrenia, Biological Psychiatry, vol.30, issue.4, pp.349-56, 1991.
DOI : 10.1016/0006-3223(91)90290-3

K. Iwabuchi, C. Ito, M. Tashiro, M. Kato, M. Kano et al., Histamine H1 receptors in schizophrenic patients measured by positron emission tomography, European Neuropsychopharmacology, vol.15, issue.2, pp.185-91, 2005.
DOI : 10.1016/j.euroneuro.2004.10.001

J. Arrang and J. Schwartz, Histamine and Schizophrenia
DOI : 10.1016/S0074-7742(06)78009-6
URL : https://hal.archives-ouvertes.fr/inserm-00150117

P. Protais, J. Costentin, and J. Schwartz, Climbing behavior induced by apomorphine in mice: a simple test for the study of dopamine receptors in striatum, Psychopharmacology, vol.31, issue.Suppl. 82, pp.1-6, 1976.
DOI : 10.1007/BF00634146

J. Valatx and R. Bugat, Facteurs g??n??tiques dans le d??terminisme du cycle veille-sommeil chez la souris, Brain Research, vol.69, issue.2, pp.315-345, 1974.
DOI : 10.1016/0006-8993(74)90009-2

R. Parmentier, H. Ohtsu, Z. Djebbara-hannas, J. Valatx, T. Watanabe et al., Anatomical, physiological, and pharmacological characteristics of histidine decarboxylase knock-out mice: evidence for the role of brain histamine in behavioral and sleep-wake control

X. Ligneau, J. Lin, G. Vanni-mercier, M. Jouvet, J. Muir et al., Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist, J Pharmacol Exp Ther, vol.287, pp.658-66, 1998.

J. Chen, C. Liu, and T. Lovenberg, Molecular and pharmacological characterization of the mouse histamine H3 receptor, European Journal of Pharmacology, vol.467, issue.1-3, pp.57-65, 2003.
DOI : 10.1016/S0014-2999(03)01635-2

T. Lovenberg, J. Pyati, H. Chang, and S. Wilson, Erlander MG Cloning of rat histamine H(3) receptor reveals distinct species pharmacological profiles, J Pharmacol Exp Ther, vol.293, pp.771-779, 2000.

J. Clapham and G. Kilpatrick, Thioperamide, the selective histamine H3 receptor antagonist, attenuates stimulant-induced locomotor activity in the mouse, European Journal of Pharmacology, vol.259, issue.2, pp.107-121, 1994.
DOI : 10.1016/0014-2999(94)90498-7

M. Imaizumi and K. Onodera, The behavioral and biochemical effects of thioperamide, a histamine H3-receptor antagonist, in a light/dark test measuring anxiety in mice, Life Sciences, vol.53, issue.22, pp.1675-83, 1993.
DOI : 10.1016/0024-3205(93)90204-G

C. Pillot, J. Ortiz, A. Heron, S. Ridray, J. Schwartz et al., Ciproxifan, a histamine H3-receptor antagonist/inverse agonist, potentiates neurochemical and behavioral effects of haloperidol in the rat, J Neurosci, vol.22, pp.7272-80, 2002.
URL : https://hal.archives-ouvertes.fr/hal-01490023

V. Komater, K. Browman, P. Curzon, A. Hancock, M. Decker et al., H3 receptor blockade by thioperamide enhances cognition in rats without inducing locomotor sensitization, Psychopharmacology, vol.289, issue.4, pp.363-72, 2003.
DOI : 10.1016/S0149-7634(99)00061-5

C. Sadakhom, H. Frances, J. Arrang, C. Dugovic, M. Koehl et al., Ciproxifan, a histamine H3-receptor antagonist/inverse agonist, modulates methamphetamine-and apomorphine-induced stereotyped behaviors in mice, Behavioral characterization of mice lacking histamine H(3) receptors

P. Andine, N. Widermark, R. Axelsson, G. Nyberg, U. Olofsson et al., Characterization of MK-801-induced behavior as a putative rat model of psychosis, J Pharmacol Exp Ther, vol.290, pp.1393-408, 1999.

M. Carlsson and A. Carlsson, Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease, Trends in Neurosciences, vol.13, issue.7, pp.272-278, 1990.
DOI : 10.1016/0166-2236(90)90108-M

M. Geyer, K. Krebs-thomson, D. Braff, and N. Swerdlow, Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review, Psychopharmacology, vol.156, issue.2-3, pp.117-54, 2001.
DOI : 10.1007/s002130100811

P. Curzon and M. Decker, Effects of phencyclidne (PCP) and (+)MK-801 on sensorimotor gating in CD-1 mice, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.22, issue.1, pp.129-175, 1998.
DOI : 10.1016/S0278-5846(97)00184-X

S. Dulawa and M. Geyer, Psychopharmacology of prepulse inhibition in mice, Chin J Physiol, vol.39, pp.139-185, 1996.

G. Varty, N. Walters, M. Cohen-williams, and G. Carey, Comparison of apomorphine, amphetamine and dizocilpine disruptions of prepulse inhibition in inbred and outbred mice strains, European Journal of Pharmacology, vol.424, issue.1, pp.27-36, 2001.
DOI : 10.1016/S0014-2999(01)01115-3

K. Browman, V. Komater, P. Curzon, L. Rueter, A. Hancock et al., Enhancement of prepulse inhibition of startle in mice by the H3 receptor antagonists thioperamide and ciproxifan, Behavioural Brain Research, vol.153, issue.1, pp.69-76, 2004.
DOI : 10.1016/j.bbr.2003.11.001

G. Fox, T. Esbenshade, J. Pan, R. Radek, K. Krueger et al., Pharmacological Properties of ABT-239 [4-(2-??-benzofuran-5-yl)benzonitrile]: II. Neurophysiological Characterization and Broad Preclinical Efficacy in Cognition and Schizophrenia of a Potent and Selective Histamine H3 Receptor Antagonist, Journal of Pharmacology and Experimental Therapeutics, vol.313, issue.1, pp.176-90, 2005.
DOI : 10.1124/jpet.104.078402

H. Meltzer, What's atypical about atypical antipsychotic drugs?, Current Opinion in Pharmacology, vol.4, issue.1, pp.53-60, 2004.
DOI : 10.1016/j.coph.2003.09.010